SURG Insider Trading
SurgePays, Inc. | Telephone Communications (No Radiotelephone)
Comprehensive Trading Performance Summary
The investment history of corporate insiders at SurgePays, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Telephone Communications (No Radiotelephone) sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2020-10-30 23:21 | 2020-10-28 | Evers Anthony George | Officer - CHIEF FINANCIAL OFFICER | BUY | $0.10 | 5,000 | $475 | 316,600 | +1.6% |
| 2020-10-30 23:20 | 2020-10-28 | Cox Kevin Brian | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | BUY | $0.09 | 4,900 | $453 | 19,801,611 | +0.0% |
| 2020-10-30 20:53 | 2020-10-27 | Cox Kevin Brian | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | BUY | $0.10 | 250,000 | $25,000 | 19,796,711 | +1.3% |
| 2020-10-29 23:28 | 2020-10-27 | Evers Anthony George | Officer - CHIEF FINANCIAL OFFICER | BUY | $0.10 | 50,000 | $5,000 | 311,600 | +19.1% |
| 2020-10-29 00:14 | 2020-10-22 | Cox Kevin Brian | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | BUY | $0.10 | 126,800 | $12,680 | 19,546,711 | +0.7% |
| 2020-10-29 00:13 | 2020-10-26 | Evers Anthony George | Officer - CHIEF FINANCIAL OFFICER | BUY | $0.10 | 50,000 | $5,000 | 261,600 | +23.6% |
| 2020-10-22 23:45 | 2020-10-20 | Evers Anthony George | Officer - CHIEF FINANCIAL OFFICER | BUY | $0.10 | 9,100 | $910 | 211,600 | +4.5% |
| 2020-10-20 21:08 | 2020-10-16 | Cox Kevin Brian | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | BUY | $0.11 | 5,625 | $619 | 19,419,911 | +0.0% |
| 2015-01-02 23:01 | 2014-12-31 | Fanning Michael | Officer - VP of Domestic Sales | SELL | $4.32 | 5,000 | $21,600 | 78,978 | -6.0% |
| 2014-12-30 03:14 | 2014-12-22 | Fanning Michael | Officer - VP of Domestic Sales | SELL | $4.25 | 13,000 | $55,231 | 83,978 | -13.4% |
| 2014-10-21 22:11 | 2014-10-20 | Thomas David Graeme | Director | BUY | $3.37 | 1,000 | $3,372 | 3,000 | +50.0% |
| 2014-03-27 17:24 | 2014-03-26 | Hable David M | Director, Officer - President and CEO | BUY | $3.04 | 3,257 | $9,905 | 110,195 | +3.0% |
| 2014-03-24 18:06 | 2014-03-21 | Thomas David Graeme | Director | BUY | $3.07 | 1,000 | $3,074 | 2,000 | +100.0% |
| 2014-01-08 00:04 | 2014-01-03 | Fanning Michael | Officer - VP of Domestic Sales | SELL | $3.47 | 2,290 | $7,958 | 76,978 | -2.9% |
| 2014-01-06 23:20 | 2013-12-12 | Thomas David Graeme | Director | BUY | $3.55 | 1,000 | $3,550 | 1,000 | +100.0% |
| 2013-10-19 00:00 | 2013-10-16 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $4.57 | 10,000 | $45,700 | 344,200 | -2.8% |
| 2013-10-17 00:32 | 2013-10-14 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $4.55 | 40,000 | $182,124 | 354,200 | -10.1% |
| 2013-10-12 02:11 | 2013-10-11 | Fanning Michael | Officer - VP of Domestic Sales | SELL | $4.67 | 4,000 | $18,691 | 79,268 | -4.8% |
| 2013-10-11 04:42 | 2013-10-08 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $4.60 | 50,605 | $232,930 | 394,200 | -11.4% |
| 2013-10-09 00:00 | 2013-10-04 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $4.50 | 49,395 | $222,208 | 444,805 | -10.0% |
| 2013-03-21 22:28 | 2013-03-20 | Fanning Michael | Officer - VP of Domestic Sales | BUY | $3.43 | 2,000 | $6,860 | 83,268 | +2.5% |
| 2013-03-19 18:00 | 2013-03-18 | Fanning Michael | Officer - VP of Domestic Sales | BUY | $3.30 | 7,300 | $24,068 | 81,268 | +9.9% |
| 2012-06-18 21:15 | 2012-06-14 | Hable David M | Director, Officer - President and CEO | BUY | $4.03 | 4,000 | $16,110 | 85,531 | +4.9% |
| 2012-06-15 17:50 | 2012-06-14 | BOONE PAMELA G | Officer - EVP & Chief Financial Officer | BUY | $4.00 | 2,800 | $11,213 | 2,800 | +100.0% |
| 2012-03-19 15:46 | 2012-03-15 | Gampp Kurt W Jr | Officer - EVP & Chief Operating Officer | BUY | $5.64 | 9,000 | $50,716 | 637,842 | +1.4% |
| 2012-03-16 17:27 | 2012-03-15 | Hable David M | Director, Officer - President and CEO | BUY | $5.86 | 4,000 | $23,440 | 81,531 | +5.2% |
| 2012-02-21 16:51 | 2012-02-17 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $7.00 | 1,500 | $10,500 | 486,805 | -0.3% |
| 2012-02-11 02:28 | 2012-02-09 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $7.00 | 2,000 | $14,000 | 488,305 | -0.4% |
| 2012-02-07 03:11 | 2012-02-03 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $7.00 | 440 | $3,080 | 490,305 | -0.1% |
| 2012-01-05 00:02 | 2012-01-03 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $7.46 | 20,000 | $149,250 | 490,745 | -3.9% |
| 2012-01-03 22:54 | 2011-12-30 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $7.36 | 10,000 | $73,600 | 490,745 | -2.0% |
| 2012-01-04 01:53 | 2011-12-30 | MALIS JERRY L | Officer - EVP & Chief Scientific Officer | SELL | $7.36 | 10,000 | $73,600 | 510,745 | -1.9% |
| 2011-12-19 17:20 | 2011-12-16 | Gampp Kurt W Jr | Officer - EVP & Chief Operating Officer | SELL | $7.00 | 66,000 | $462,000 | 628,842 | -9.5% |
| 2011-10-24 20:21 | 2011-10-20 | BOONE PAMELA G | Officer - EVP & Chief Financial Officer | BUY | $6.40 | 1,000 | $6,399 | 143,704 | +0.7% |
| 2011-10-20 17:59 | 2011-10-18 | Williams Patricia S | Director | BUY | $6.22 | 1,500 | $9,330 | 4,500 | +50.0% |
| 2011-10-13 22:44 | 2011-10-11 | Gampp Kurt W Jr | Director, Officer - EVP & Chief Operating Officer | SELL | $6.00 | 44,600 | $267,600 | 669,842 | -6.2% |
| 2011-04-07 21:39 | 2011-04-07 | BOONE PAMELA G | Officer - EVP & Chief Financial Officer | BUY | $5.36 | 2,000 | $10,720 | 142,704 | +1.4% |
| 2011-04-06 23:00 | 2011-04-04 | Gampp Kurt W Jr | Director, Officer - EVP & Chief Operating Officer | SELL | $6.00 | 47,800 | $286,800 | 714,442 | -6.3% |
| 2011-03-24 18:48 | 2011-03-22 | Gampp Kurt W Jr | Director, Officer - EVP & Chief Operating Officer | SELL | $6.00 | 7,600 | $45,600 | 762,242 | -1.0% |
| 2011-03-22 17:00 | 2011-03-21 | Gampp Kurt W Jr | Director, Officer - EVP & Chief Operating Officer | SELL | $5.55 | 57,000 | $316,401 | 769,842 | -6.9% |
| 2011-03-15 22:07 | 2011-03-11 | Gampp Kurt W Jr | Director, Officer - EVP & Chief Operating Officer | SELL | $5.50 | 43,000 | $236,560 | 826,842 | -4.9% |
| 2011-03-15 17:50 | 2011-03-11 | MALIS JERRY L | Director, Officer - Chief Scientific Officer | SELL | $5.49 | 91,400 | $501,786 | 500,745 | -15.4% |
| 2011-02-11 00:35 | 2011-02-09 | MALIS JERRY L | Director, Officer - Chief Scientific Officer | SELL | $5.26 | 108,600 | $571,214 | 592,145 | -15.5% |
| 2011-01-27 22:28 | 2011-01-26 | MALIS JERRY L | Director, Officer - Chief Scientific Officer | SELL | $4.92 | 150,000 | $738,720 | 700,745 | -17.6% |
| 2011-01-25 18:15 | 2011-01-21 | MALIS JERRY L | Director, Officer - Chief Scientific Officer | SELL | $4.66 | 29,782 | $138,701 | 850,745 | -3.4% |
| 2011-01-21 22:13 | 2011-01-19 | MALIS JERRY L | Director, Officer - Chief Scientific Officer | SELL | $4.65 | 34,218 | $159,151 | 880,527 | -3.7% |
| 2011-01-07 20:02 | 2011-01-06 | Hable David M | Director, Officer - President and CEO | OPT+S | $4.88 | 17,000 | $82,960 | 21,417 | 0.0% |
| 2011-01-05 22:19 | 2011-01-04 | BOONE PAMELA G | Officer - EVP & Chief Financial Officer | BUY | $4.67 | 2,500 | $11,674 | 140,704 | +1.8% |
| 2010-10-19 23:56 | 2010-10-19 | GUARCH GUY R | Director | BUY | $2.95 | 2,000 | $5,900 | 6,000 | +50.0% |
| 2010-10-20 00:01 | 2010-10-18 | BOONE PAMELA G | Officer - EVP & Chief Financial Officer | BUY | $2.91 | 5,000 | $14,550 | 138,204 | +3.8% |
How to Interpret $SURG Trades
Not every insider transaction in SurgePays, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SURG shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for SURG
Insider activity data for SurgePays, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SURG, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.